INS and type 1 diabetes mellitus: Wang et al. [98] showed that in subjects with type 1 diabetes, the addition of a probiotic supplement to conventional insulin therapy enriched the intestinal microbial composition, with increases in Bifidobacterium animalis, Lactobacillus salivarius, and A. muciniphila compared to insulin therapy alone.